The pro-inflammatory cytokine IL-17 is speculated to play a major role in the destructive inflammation observed in IBD, specifically through the upregulation of additional pro-inflammatory cytokines, such as TNF-α, IL-1β, and IL-6 [1,22]. Here, IL17A is linked to inflammatory bowel disease.